ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
MS
Menarini Stemline at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Menarini Stemline takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 8065. Its program centres on advanced breast cancer with ESR1 mutations and the changing options for treating it. The topic ties to elacestrant, its medicine for oestrogen receptor-positive, HER2-negative advanced breast cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
MS Menarini Stemline | |
Oncology business of the Menarini Group, marketing medicines including elacestrant for ER-positive, HER2-negative advanced breast cancer. | Booth Exhibiting at Booth 8065 Satellite Fri Oct 23 18:15–19:45 Menarini Stemline - ESR1-mutated Advanced Breast Cancer: A Transforming Treatment Landscape Breast cancerBiomarkers & precision oncology |
Find decision makers at Menarini Stemline
Tell us what you sell and we’ll find the people at Menarini Stemline most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction